NCT06834932: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
- State
- Under way
- Phase
- Phase 2 and Phase 3
- People
- 432 taking part
- Started
- 6 Dec 2024
- Primary completion
- 22 Feb 2027
- Arms
- AZD0780 +Rosuvastatin Dose 1 (Part A), AZD0780 +Rosuvastatin Dose 2 (Part A), AZD0780 (Part B Cohort 1), AZD0780+Rosuvastatin Dose 1 (Part B Cohort 2)
- Results
- None posted
- 6 Dec 2024: Trial started
- 19 Feb 2025: Trial registered